Liabilities / Assets
Score unavailable
Liabilities-to-assets requires both liabilities and assets on the latest valid filing.
EIN 46-1995761 • 501(c)3 • Orient, NY
Profile
The mission of ilrog is to improve the outcome for patients by encouraging the appropriate integration of radiation therapy in the management of lymphoma. Ilrog objectives: - to optimize, advance and harmonize the integration of radiation therapy in the management of lymphoma patients. - to inform the hematology, medical and radiation oncology communities of the lymphoma scenarios where appropriate utilization of radiotherapy is advantageous. - to develop and disseminate evidence-based guidelines for radiotherapy fields, doses and techniques for all types of lymphomas. - to train radiation oncologists worldwide in using modern lymphoma radiotherapy principles and techniques via collaboration with appropriate national or regional scientific societies. - to provide a worldwide forum for radiation oncologists who treat lymphomas to discuss and share information and ideas. - to provide a source of information for lymphoma patients explaining the advantages and risks associated with radiati
Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.
Liabilities / Assets
Score unavailable
Liabilities-to-assets requires both liabilities and assets on the latest valid filing.
Liabilities / Revenue
Score unavailable
Liabilities-to-revenue requires both liabilities and revenue on the latest valid filing.
Net Margin
59th percentile
Higher net margin than 59% of similar nonprofits.
Top Officer Pay
79th percentile
Higher top officer pay than 79% of similar nonprofits.
Top officer pay equals 0.0% of source-year revenue.
Asset Growth
61st percentile
Faster asset growth than 61% of similar nonprofits.
Revenue Growth
48th percentile
Faster revenue growth than 48% of similar nonprofits.
Assets
Up$166,978
Up $12,007 (+7.7%) from 2023
Liabilities
-
No earlier filing loaded for comparison.
Net Assets
Up$166,978
Up $12,007 (+7.7%) from 2023
Revenue
Up$84,748
Up $436 (+0.5%) from 2023
Expenses
Down$72,740
Down $4,259 (-5.5%) from 2023
Net Income
Up$12,008
Up $4,695 (+64%) from 2023
Most recent year
2024 • Form 990EZDetailed filing. Detailed filing data is available for this year.
The mission of ilrog is to improve the outcome for patients by encouraging the appropriate integration of radiation therapy in the management of lymphoma. Ilrog objectives: - to optimize, advance and harmonize the integration of radiation therapy in the management of lymphoma patients. - to inform the hematology, medical and radiation oncology communities of the lymphoma scenarios where appropriate utilization of radiotherapy is advantageous. - to develop and disseminate evidence-based guidelines for radiotherapy fields, doses and techniques for all types of lymphomas. - to train radiation oncologists worldwide in using modern lymphoma radiotherapy principles and techniques via collaboration with appropriate national or regional scientific societies. - to provide a worldwide forum for radiation oncologists who treat lymphomas to discuss and share information and ideas. - to provide a source of information for lymphoma patients explaining the advantages and risks associated with radiati
| Description | Grants | Expenses |
|---|---|---|
| 2024 ACCOMPLISHMENTS INCLUDE CONTINUED EDUCATION OF MEMBERSHIP BY CREATING, PUBLISHING AND CREATING GUIDELINES. MULTICENTER COLLABORATION ON RESEARCH PROJECTS. AN INTERNATIONAL CONFERENCE WAS HELD IN BEIJING, CHINA. | - | $68,780 |
| Name | Title | Full / Part Time | Base | Other | Total |
|---|---|---|---|---|---|
| JOACHIM YAHALOM MD | Chairman | PT | $0 | - | - |
| LENA SPECHT MD | Vice-Chairma | PT | $0 | - | - |
| TIM ILLIDGE MD | Secretary/Tr | PT | $0 | - | - |
“Expenses office expenses 120 website/hosting 1,191 technology expenses 6,084 conferences & meetings 10,046 bank fees 1,990 payroll processing fees 913 dues & subscriptions 637 awards and host gifts 2,182 total 23,163”
“The mission of ilrog is to improve the outcome for patients by encouraging the appropriate integration of radiation therapy in the management of lymphoma. Ilrog objectives: - to optimize, advance and harmonize the integration of radiation therapy in the management of lymphoma patients. - to inform the hematology, medical and radiation oncology communities of the lymphoma scenarios where appropriate utilization of radiotherapy is advantageous. - to develop and disseminate evidence-based guidelines for radiotherapy fields, doses and techniques for all types of lymphomas. - to train radiation oncologists worldwide in using modern lymphoma radiotherapy principles and techniques via collaboration with appropriate national or regional scientific societies. - to provide a worldwide forum for radiation oncologists who treat lymphomas to discuss and share information and ideas. - to provide a source of information for lymphoma patients explaining the advantages and risks associated with radiation therapy. - to initiate, support and conduct research that will further the understanding of radiotherapy in the treatment of lymphoma and that will improve the therapeutic ratio of using radiotherapy alone or in combination with other therapies.”
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| IRS990EZ/ActivitiesNotPreviouslyRptInd | 0 | false |
| IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt | 0 | INTERNATIONAL LYMPHOMA RADIATION |
| IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine2Txt | 0 | INTERNATIONAL LYMPHOMA RADIATION |
| IRS990EZ/BooksInCareOfDetail/PhoneNum | 0 | 2126395999 |
| IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 351 E 51ST ST APT 14C |
| IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine2Txt | 0 | 35 E 51ST ST APT 14C |
| IRS990EZ/BooksInCareOfDetail/USAddress/CityNm | 0 | NEW YORK |
| IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | NY |
| IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 10022 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt | 0 | 154970 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt | 0 | 166978 |
| IRS990EZ/ChgMadeToOrgnzngDocNotRptInd | 0 | false |
| IRS990EZ/ContributionsGiftsGrantsEtcAmt | 0 | 40000 |
| IRS990EZ/DonorAdvisedFndsInd | 0 | false |
| IRS990EZ/EngagedInExcessBenefitTransInd | 0 | false |
| IRS990EZ/ExcessOrDeficitForYearAmt | 0 | 12008 |
| IRS990EZ/FeesAndOtherPymtToIndCntrctAmt | 0 | 420 |
| IRS990EZ/FiledScheduleAInd | 0 | true |
| IRS990EZ/ForeignFinancialAccountInd | 0 | false |
| IRS990EZ/ForeignOfficeInd | 0 | false |
| IRS990EZ/Form1120PolFiledInd | 0 | false |
| IRS990EZ/Form990TotalAssetsGrp/BOYAmt | 0 | 154970 |
| IRS990EZ/Form990TotalAssetsGrp/EOYAmt | 0 | 166978 |
| IRS990EZ/GrossReceiptsAmt | 0 | 84748 |
| IRS990EZ/InfoInScheduleOPartIIIInd | 0 | X |
| IRS990EZ/InfoInScheduleOPartIInd | 0 | X |
| IRS990EZ/InvestmentIncomeAmt | 0 | 153 |
| IRS990EZ/LobbyingActivitiesInd | 0 | false |
| IRS990EZ/MadeLoansToFromOfficersInd | 0 | false |
| IRS990EZ/MembershipDuesAmt | 0 | 44595 |
| IRS990EZ/MethodOfAccountingCashInd | 0 | X |
| IRS990EZ/NetAssetsOrFundBalancesBOYAmt | 0 | 154970 |
| IRS990EZ/NetAssetsOrFundBalancesEOYAmt | 0 | 166978 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt | 0 | 154970 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt | 0 | 166978 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 0 | 12.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 1 | 8.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 2 | 8.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 0 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 1 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 2 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 0 | JOACHIM YAHALOM MD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 1 | LENA SPECHT MD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 2 | TIM ILLIDGE MD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 0 | CHAIRMAN |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 1 | VICE-CHAIRMA |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 2 | SECRETARY/TR |
| IRS990EZ/OperateHospitalInd | 0 | false |
| IRS990EZ/Organization501c3Ind | 0 | X |
| IRS990EZ/OrganizationDissolvedEtcInd | 0 | false |
| IRS990EZ/OrganizationHadUBIInd | 0 | false |
| IRS990EZ/OtherExpensesTotalAmt | 0 | 23163 |
| IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt | 0 | NONE |
| IRS990EZ/PartVIOfCompOfHghstPdEmplTxt | 0 | NONE |
| IRS990EZ/PoliticalCampaignActyInd | 0 | false |
| IRS990EZ/PrimaryExemptPurposeTxt | 0 | THE MISSION OF ILROG IS TO IMPROVE THE OUTCOME FOR PATIENTS BY ENCOURAGING THE APPROPRIATE INTEGRATION OF RADIATION THERAPY IN THE MANAGEMENT OF LYMPHOMA. ILROG OBJECTIVES: - TO OPTIMIZE, ADVANCE AND HARMONIZE THE INTEGRATION OF RADIATION THERAPY IN THE MANAGEMENT OF LYMPHOMA PATIENTS. - TO INFORM THE HEMATOLOGY, MEDICAL AND RADIATION ONCOLOGY COMMUNITIES OF THE LYMPHOMA SCENARIOS WHERE APPROPRIATE UTILIZATION OF RADIOTHERAPY IS ADVANTAGEOUS. - TO DEVELOP AND DISSEMINATE EVIDENCE-BASED GUIDELINES FOR RADIOTHERAPY FIELDS, DOSES AND TECHNIQUES FOR ALL TYPES OF LYMPHOMAS. - TO TRAIN RADIATION ONCOLOGISTS WORLDWIDE IN USING MODERN LYMPHOMA RADIOTHERAPY PRINCIPLES AND TECHNIQUES VIA COLLABORATION WITH APPROPRIATE NATIONAL OR REGIONAL SCIENTIFIC SOCIETIES. - TO PROVIDE A WORLDWIDE FORUM FOR RADIATION ONCOLOGISTS WHO TREAT LYMPHOMAS TO DISCUSS AND SHARE INFORMATION AND IDEAS. - TO PROVIDE A SOURCE OF INFORMATION FOR LYMPHOMA PATIENTS EXPLAINING THE ADVANTAGES AND RISKS ASSOCIATED WITH RADIATI |
| IRS990EZ/PrintingPublicationsPostageAmt | 0 | 603 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt | 0 | 2024 ACCOMPLISHMENTS INCLUDE CONTINUED EDUCATION OF MEMBERSHIP BY CREATING, PUBLISHING AND CREATING GUIDELINES. MULTICENTER COLLABORATION ON RESEARCH PROJECTS. AN INTERNATIONAL CONFERENCE WAS HELD IN BEIJING, CHINA. |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt | 0 | 68780 |
| IRS990EZ/ProhibitedTaxShelterTransInd | 0 | false |
| IRS990EZ/RelatedOrganizationCtrlEntInd | 0 | false |
| IRS990EZ/SalariesOtherCompEmplBnftAmt | 0 | 48554 |
| IRS990EZ/SchoolOperatingInd | 0 | false |
| IRS990EZ/SubjectToProxyTaxInd | 0 | false |
| IRS990EZ/TanningServicesProvidedInd | 0 | false |
| IRS990EZ/TotalExpensesAmt | 0 | 72740 |
| IRS990EZ/TotalProgramServiceExpensesAmt | 0 | 68780 |
| IRS990EZ/TotalRevenueAmt | 0 | 84748 |
| IRS990EZ/TransactionWithControlEntInd | 0 | false |
| IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd | 0 | false |
| IRS990EZ/TypeOfOrganizationCorpInd | 0 | X |
| IRS990EZ/WebsiteAddressTxt | 0 | WWW.ILROG.COM |
| IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt | 0 | RESEARCH 40,000 |
| IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc | 0 | SUPPORTING SCHEDULE |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt | 0 | 44595 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt | 0 | 44185 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 35058 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 31583 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 52029 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt | 0 | 207450 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt | 0 | 153 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus1YearAmt | 0 | 127 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 184 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt | 0 | 464 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt | 0 | 153 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt | 0 | 127 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus4YearsAmt | 0 | 184 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt | 0 | 464 |
| IRS990ScheduleA/InvestmentIncomeCYPct | 0 | 0.00000 |
| IRS990ScheduleA/InvestmentIncomePYPct | 0 | 0.00000 |
| IRS990ScheduleA/PubliclySupportedOrg509a2Ind | 0 | X |
| IRS990ScheduleA/PublicSupportCY509Pct | 0 | 0.99780 |
| IRS990ScheduleA/PublicSupportPY509Pct | 0 | 0.99620 |
| IRS990ScheduleA/PublicSupportTotal509Amt | 0 | 207450 |
| IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind | 0 | X |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt | 0 | 44595 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt | 0 | 44185 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 35058 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 31583 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 52029 |
| IRS990ScheduleA/Total509Grp/TotalAmt | 0 | 207450 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt | 0 | 44748 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt | 0 | 44312 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt | 0 | 35058 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt | 0 | 31583 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt | 0 | 52213 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt | 0 | 207914 |
| IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorNum | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine2 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt | 0 | RESTRICTED |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 0 | EXPENSES OFFICE EXPENSES 120 WEBSITE/HOSTING 1,191 TECHNOLOGY EXPENSES 6,084 CONFERENCES & MEETINGS 10,046 BANK FEES 1,990 PAYROLL PROCESSING FEES 913 DUES & SUBSCRIPTIONS 637 AWARDS AND HOST GIFTS 2,182 TOTAL 23,163 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 1 | THE MISSION OF ILROG IS TO IMPROVE THE OUTCOME FOR PATIENTS BY ENCOURAGING THE APPROPRIATE INTEGRATION OF RADIATION THERAPY IN THE MANAGEMENT OF LYMPHOMA. ILROG OBJECTIVES: - TO OPTIMIZE, ADVANCE AND HARMONIZE THE INTEGRATION OF RADIATION THERAPY IN THE MANAGEMENT OF LYMPHOMA PATIENTS. - TO INFORM THE HEMATOLOGY, MEDICAL AND RADIATION ONCOLOGY COMMUNITIES OF THE LYMPHOMA SCENARIOS WHERE APPROPRIATE UTILIZATION OF RADIOTHERAPY IS ADVANTAGEOUS. - TO DEVELOP AND DISSEMINATE EVIDENCE-BASED GUIDELINES FOR RADIOTHERAPY FIELDS, DOSES AND TECHNIQUES FOR ALL TYPES OF LYMPHOMAS. - TO TRAIN RADIATION ONCOLOGISTS WORLDWIDE IN USING MODERN LYMPHOMA RADIOTHERAPY PRINCIPLES AND TECHNIQUES VIA COLLABORATION WITH APPROPRIATE NATIONAL OR REGIONAL SCIENTIFIC SOCIETIES. - TO PROVIDE A WORLDWIDE FORUM FOR RADIATION ONCOLOGISTS WHO TREAT LYMPHOMAS TO DISCUSS AND SHARE INFORMATION AND IDEAS. - TO PROVIDE A SOURCE OF INFORMATION FOR LYMPHOMA PATIENTS EXPLAINING THE ADVANTAGES AND RISKS ASSOCIATED WITH RADIATION THERAPY. - TO INITIATE, SUPPORT AND CONDUCT RESEARCH THAT WILL FURTHER THE UNDERSTANDING OF RADIOTHERAPY IN THE TREATMENT OF LYMPHOMA AND THAT WILL IMPROVE THE THERAPEUTIC RATIO OF USING RADIOTHERAPY ALONE OR IN COMBINATION WITH OTHER THERAPIES. |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | FORM 990-EZ, PART I, LINE 16 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 1 | FORM 990-EZ, PART III |
| ReturnHeader/BuildTS | 0 | 2025-03-06 01:10:19Z |
| ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd | 0 | true |
| ReturnHeader/BusinessOfficerGrp/PersonNm | 0 | JOACHIM YAHALOM MD |
| ReturnHeader/BusinessOfficerGrp/PersonTitleTxt | 0 | CHAIRMAN |
| ReturnHeader/BusinessOfficerGrp/PhoneNum | 0 | 2126395999 |
| ReturnHeader/BusinessOfficerGrp/SignatureDt | 0 | 2025-10-31 |
| ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt | 0 | INTERNATIONAL LYMPHOMA RADIATION |
| ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt | 0 | ONCOLOGY FOUNDATION |
| ReturnHeader/Filer/BusinessNameControlTxt | 0 | INTE |
| ReturnHeader/Filer/EIN | 0 | 461995761 |
| ReturnHeader/Filer/PhoneNum | 0 | 2126395999 |
| ReturnHeader/Filer/USAddress/AddressLine1Txt | 0 | 965 EDWARDS LANE |
| ReturnHeader/Filer/USAddress/CityNm | 0 | ORIENT |
| ReturnHeader/Filer/USAddress/StateAbbreviationCd | 0 | NY |
| ReturnHeader/Filer/USAddress/ZIPCd | 0 | 119571031 |
| ReturnHeader/IRSResponsiblePrtyInfoCurrInd | 0 | false |
| ReturnHeader/PreparerFirmGrp/PreparerFirmEIN | 0 | 522436535 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt | 0 | COMER & COMPANY CPA'S LLC |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt | 0 | 61 MAIN STREET |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm | 0 | MIDDLETOWN |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd | 0 | CT |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd | 0 | 064573408 |
| ReturnHeader/PreparerPersonGrp/PhoneNum | 0 | 8603462100 |
| ReturnHeader/PreparerPersonGrp/PreparationDt | 0 | 2025-10-31 |
| ReturnHeader/PreparerPersonGrp/PreparerPersonNm | 0 | THOMAS D COMER CPA |
| ReturnHeader/ReturnTs | 0 | 2025-11-12T13:54:36-05:00 |
| ReturnHeader/ReturnTypeCd | 0 | 990EZ |
| ReturnHeader/TaxPeriodBeginDt | 0 | 2024-01-01 |
| ReturnHeader/TaxPeriodEndDt | 0 | 2024-12-31 |
| ReturnHeader/TaxYr | 0 | 2024 |
No mirrored PDF or thumbnail assets are attached yet.